Role of platelets in NOX2 activation mediated by TNFα in heart failure

[1]  L. A. Bonet,et al.  ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 , 2010, European journal of heart failure.

[2]  T. Koh,et al.  Nox2 and Nox4 mediate tumour necrosis factor-α-induced ventricular remodelling in mice , 2011, Journal of cellular and molecular medicine.

[3]  A. Plebani,et al.  Inherited Human gp91phox Deficiency Is Associated With Impaired Isoprostane Formation and Platelet Dysfunction , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[4]  S. Basili,et al.  Atorvastatin Inhibits gp91phox Circulating Levels in Patients With Hypercholesterolemia , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[5]  J. Freedman,et al.  Stimulation of Toll-Like Receptor 2 in Human Platelets Induces a Thromboinflammatory Response Through Activation of Phosphoinositide 3-Kinase , 2009, Circulation research.

[6]  A. Blum.  Heart failure--new insights. , 2009, The Israel Medical Association journal : IMAJ.

[7]  Michael Böhm,et al.  Kommentar zu den ESC-Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 , 2008, European journal of heart failure.

[8]  F. Violi,et al.  Tumour necrosis factor alpha upregulates platelet CD40L in patients with heart failure. , 2008, Cardiovascular research.

[9]  Simon J. Walker,et al.  Reduced nicotinamide adenine dinucleotide phosphate oxidase-derived superoxide and vascular endothelial dysfunction in human heart failure. , 2008, Journal of the American College of Cardiology.

[10]  G. Lip,et al.  Platelet activation in acute, decompensated congestive heart failure. , 2007, Thrombosis research.

[11]  Simon J. Walker,et al.  NADPH oxidases in cardiovascular health and disease. , 2006, Antioxidants & redox signaling.

[12]  A. Shah,et al.  Involvement of the nicotinamide adenosine dinucleotide phosphate oxidase isoform Nox2 in cardiac contractile dysfunction occurring in response to pressure overload. , 2006, Journal of the American College of Cardiology.

[13]  M. Volpe,et al.  Tumor necrosis factor-α as trigger of platelet activation in patients with heart failure , 2005 .

[14]  K. Dickstein,et al.  Soluble CD40 ligand in acute and chronic heart failure. , 2005, European heart journal.

[15]  A. Hoes,et al.  Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. , 2005, European heart journal.

[16]  M. Volpe,et al.  Tumor necrosis factor-alpha as trigger of platelet activation in patients with heart failure. , 2005, Blood.

[17]  F. Violi,et al.  gp91phox-Dependent Expression of Platelet CD40 Ligand , 2004, Circulation.

[18]  W. Daniel,et al.  Enhanced levels of CD154 (CD40 ligand) on platelets in patients with chronic heart failure , 2003, European journal of heart failure.

[19]  M. Volpe,et al.  Enhanced TNFα and oxidative stress in patients with heart failure: effect of TNFα on platelet O2 - production , 2003, Thrombosis and Haemostasis.

[20]  A. Shah,et al.  Increased myocardial NADPH oxidase activity in human heart failure. , 2003, Journal of the American College of Cardiology.

[21]  Douglas L Mann,et al.  Inflammatory mediators and the failing heart: past, present, and the foreseeable future. , 2002, Circulation research.

[22]  D. Praticò,et al.  Platelet-derived microparticles stimulate proliferation, survival, adhesion, and chemotaxis of hematopoietic cells. , 2002, Experimental hematology.

[23]  D. Wagner,et al.  The role of tumor necrosis factor in the pathophysiology of heart failure. , 2000, Journal of the American College of Cardiology.

[24]  G. Lip,et al.  Does heart failure confer a hypercoagulable state? Virchow's triad revisited. , 1999, Journal of the American College of Cardiology.

[25]  H. Oral,et al.  Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD). , 1996, Journal of the American College of Cardiology.

[26]  H. Fillit,et al.  Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. , 1990, The New England journal of medicine.